| Primary |
| Product Used For Unknown Indication |
100.0% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
27.0% |
| Hypertension |
12.5% |
| Thrombosis Prophylaxis |
9.9% |
| Antiplatelet Therapy |
7.9% |
| Dialysis |
4.6% |
| Anticoagulant Therapy |
3.9% |
| Product Used For Unknown Indication |
3.3% |
| Pulmonary Embolism |
3.3% |
| Metastatic Renal Cell Carcinoma |
2.6% |
| Nausea |
2.6% |
| Non-small Cell Lung Cancer |
2.6% |
| Osteitis |
2.6% |
| Renal Failure |
2.6% |
| Thrombosis |
2.6% |
| Acute Myocardial Infarction |
2.0% |
| Diabetes Mellitus |
2.0% |
| Diffuse Large B-cell Lymphoma Recurrent |
2.0% |
| Neuralgia |
2.0% |
| Osteoporosis Postmenopausal |
2.0% |
| Venous Thrombosis Limb |
2.0% |
|
| Intravascular Haemolysis |
10.0% |
| Cerebral Haemorrhage |
7.5% |
| Neutropenia |
7.5% |
| Post Procedural Haematoma |
7.5% |
| Basophilia |
5.0% |
| Cerebrovascular Accident |
5.0% |
| Cholestasis |
5.0% |
| Cytolytic Hepatitis |
5.0% |
| Dermatitis Exfoliative |
5.0% |
| Haemolysis |
5.0% |
| Pruritus |
5.0% |
| Pyrexia |
5.0% |
| Rash Maculo-papular |
5.0% |
| Rash Papular |
5.0% |
| Sensory Loss |
5.0% |
| Abortion Induced |
2.5% |
| Arthroscopy |
2.5% |
| Death |
2.5% |
| Deep Vein Thrombosis |
2.5% |
| Dementia |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.0% |
| Product Used For Unknown Indication |
15.2% |
| Prophylaxis |
12.9% |
| Thrombosis Prophylaxis |
6.9% |
| Hypertension |
6.1% |
| Pain |
5.8% |
| Crohn's Disease |
4.5% |
| Nausea |
4.4% |
| Non-small Cell Lung Cancer |
3.9% |
| Diarrhoea |
3.1% |
| Diffuse Large B-cell Lymphoma |
2.3% |
| Acute Myeloid Leukaemia |
2.1% |
| Coronary Artery Disease |
2.1% |
| Constipation |
2.0% |
| Multiple Myeloma |
2.0% |
| Odynophagia |
1.9% |
| Dyspepsia |
1.9% |
| Abdominal Pain |
1.7% |
| Hypokalaemia |
1.5% |
| Stomatitis |
1.5% |
|
| Thrombocytopenia |
10.2% |
| Vomiting |
10.2% |
| Respiratory Failure |
8.6% |
| Pulmonary Embolism |
7.1% |
| Renal Failure Acute |
7.1% |
| Sepsis |
6.6% |
| Nausea |
5.1% |
| Pneumonia |
5.1% |
| Renal Failure |
5.1% |
| Septic Shock |
4.6% |
| Thrombosis |
4.6% |
| Syncope |
4.1% |
| Death |
3.0% |
| Deep Vein Thrombosis |
3.0% |
| General Physical Health Deterioration |
3.0% |
| Hypotension |
3.0% |
| Neutropenia |
2.5% |
| Urinary Retention |
2.5% |
| Ventricular Fibrillation |
2.5% |
| Acute Psychosis |
2.0% |
|
| Interacting |
| Atrial Fibrillation |
33.3% |
| Cerebrovascular Accident Prophylaxis |
33.3% |
| Product Used For Unknown Indication |
33.3% |
|
|
